3.34
Schlusskurs vom Vortag:
$3.21
Offen:
$3.22
24-Stunden-Volumen:
78,647
Relative Volume:
0.42
Marktkapitalisierung:
$171.56M
Einnahmen:
$63.69M
Nettoeinkommen (Verlust:
$-44.82M
KGV:
-1.67
EPS:
-2
Netto-Cashflow:
$-30.56M
1W Leistung:
-6.44%
1M Leistung:
-7.22%
6M Leistung:
+56.07%
1J Leistung:
+51.82%
Mdxhealth Sa Stock (MDXH) Company Profile
Firmenname
Mdxhealth Sa
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie MDXH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
MDXH
Mdxhealth Sa
|
3.34 | 164.88M | 63.69M | -44.82M | -30.56M | -2.00 |
|
TMO
Thermo Fisher Scientific Inc
|
617.15 | 233.21B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
235.57 | 167.12B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
714.55 | 56.44B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
147.81 | 41.84B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
IQV
Iqvia Holdings Inc
|
244.29 | 40.96B | 15.90B | 1.28B | 2.21B | 7.2842 |
Mdxhealth Sa Stock (MDXH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-17 | Eingeleitet | Craig Hallum | Buy |
| 2024-10-31 | Eingeleitet | Lake Street | Buy |
| 2023-05-31 | Eingeleitet | TD Cowen | Outperform |
| 2022-07-18 | Fortgesetzt | Oppenheimer | Outperform |
Mdxhealth Sa Aktie (MDXH) Neueste Nachrichten
MDxHealth announces next phase of collab with University of Oxford - Yahoo Finance
Mdxhealth and University of Oxford to validate GPS test in largest randomized trial of treatment effectiveness in patients with localized prostate cancer - The Manila Times
World’s largest prostate cancer trial adds genomic test to guide care - Stock Titan
MDxHealth SA (NASDAQ:MDXH) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
MDxHealth SA (NASDAQ:MDXH) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
MDxHealth Files to Sell Up to $200 Million in Shares - marketscreener.com
MDxHealth SA to offer securities up to $200 millionSEC filing - MarketScreener
MDxHealth SA (NASDAQ:MDXH) Short Interest Update - MarketBeat
Analysts Offer Insights on Healthcare Companies: Viridian Therapeutics (VRDN), MDxHealth (MDXH) and RxSight (RXST) - The Globe and Mail
MDXH: BTIG Reiterates Buy Rating with $7 Price Target | MDXH Sto - GuruFocus
BTIG reiterates Buy rating on MDxHealth stock, maintains $7 price target By Investing.com - Investing.com South Africa
BTIG Research Reaffirms "Buy" Rating for MDxHealth (NASDAQ:MDXH) - MarketBeat
BTIG reiterates Buy rating on MDxHealth stock, maintains $7 price target - Investing.com Australia
How MDxHealth SA stock benefits from tech adoptionMarket Sentiment Review & Capital Efficient Trading Techniques - Улправда
Why MDxHealth SA stock remains undervalued2025 Valuation Update & Weekly Watchlist for Consistent Profits - Улправда
Is MDxHealth SA stock overvalued by current metricsJuly 2025 Setups & Advanced Technical Signal Analysis - Улправда
Retail Surge: How MDxHealth SA stock benefits from tech adoptionJuly 2025 Intraday Action & Weekly Setup with ROI Potential - Улправда
How MDxHealth SA stock reacts to inflationary pressuresPortfolio Gains Summary & Stepwise Trade Execution Plans - bolumsonucanavari.com
Why MDxHealth SA stock is a must watch in 20252025 Growth vs Value & AI Powered Market Entry Ideas - DonanımHaber
Can MDxHealth SA stock resist sector downturnsQuarterly Investment Review & Stock Portfolio Risk Control - Улправда
Reviewing 111 (NASDAQ:YI) & MDxHealth (NASDAQ:MDXH) - Defense World
MDxHealth SA (NASDAQ:MDXH) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
MDxHealth management to meet virtually with BTIG - MSN
MDxHealth price target raised to $7 from $5 at TD Cowen - MSN
MDXH: Upcoming Virtual Meeting Hosted by BTIG - GuruFocus
Samjo Management LLC Sells 96,718 Shares of MDxHealth SA $MDXH - MarketBeat
MDxHealth SA (NASDAQ:MDXH) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough - simplywall.st
MDxHealth SA's (NASDAQ:MDXH) market cap touched US$182m last week, benefiting both individual investors who own 46% as well as institutions - simplywall.st
Institutions profited after MDxHealth SA's (NASDAQ:MDXH) market cap rose US$17m last week but retail investors profited the most - Yahoo Finance
123,546 Shares in MDxHealth SA $MDXH Purchased by FreeGulliver LLC - MarketBeat
Is MDxHealth SA a good long term investmentEarnings Per Share Trends & Free Robust Financial Gains - earlytimes.in
How MDxHealth SA stock reacts to global recession fearsJuly 2025 Short Interest & Fast Entry and Exit Trade Plans - newser.com
Will MDxHealth SA stock rally after Fed decisions2025 Short Interest & Growth Focused Entry Point Reports - newser.com
MDxHealth (MDXH) Q3 2025 Earnings Call Transcript - AOL.com
What does recent volatility data suggest for MDxHealth SAWeekly Risk Summary & Reliable Volume Spike Trade Alerts - newser.com
Live market analysis of MDxHealth SA2025 Retail Activity & Low Risk Entry Point Tips - newser.com
How MDxHealth SA stock benefits from global expansionBull Run & Growth-Oriented Investment Plans - newser.com
How to monitor MDxHealth SA with trend dashboardsJuly 2025 Highlights & Risk Managed Investment Strategies - newser.com
Will MDxHealth SA stock deliver strong dividend growthChart Signals & Entry Point Confirmation Alerts - newser.com
FY2025 EPS Estimates for MDxHealth Reduced by William Blair - Defense World
OC500 2025: MICHAEL MCGARRITY - Orange County Business Journal
Volume spikes in MDxHealth SA stock – what they meanJuly 2025 Breakouts & Fast Gain Swing Alerts - newser.com
Market reaction to MDxHealth SA’s recent news2025 Market WrapUp & Free Technical Confirmation Trade Alerts - newser.com
MDxHealth (NASDAQ:MDXH) Price Target Raised to $7.00 - Defense World
MDxHealth price target raised to $7 from $6 at BTIG - MSN
Finanzdaten der Mdxhealth Sa-Aktie (MDXH)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):